Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » and gross profit.

This excerpt taken from the EYE 8-K filed Oct 31, 2008.

Gross Profit

 

  •  

Rose 8.5% to $165.1 million; represented 59.9% of sales.

 

  •  

Included $5.7 million of charges for inventory, manufacturing and other related costs associated with the restructuring.

 

  •  

Year-ago gross profit was reduced by approximately $20.7 million due to returns and costs and other impacts associated with the recall.

This excerpt taken from the EYE 8-K filed Aug 4, 2008.

Gross Profit

 

  •  

Rose 54.2% to $197.2 million; represented 61.5% of sales.

 

  •  

Year-ago gross profit included a $7.7 million charge as a result of inventory step-up to fair value related to the IntraLase acquisition.

 

  •  

Year-ago gross profit was negatively impacted by approximately $51 million in returns and costs associated with the recall.

This excerpt taken from the EYE 8-K filed May 1, 2008.

Gross Profit

 

  •  

Rose 19.4% to $188.1 million; represented 61.9% of sales.

 

  •  

Reflected the combined effects of the IntraLase acquisition and other unfavorable sales mix shifts.

This excerpt taken from the EYE 10-Q filed May 10, 2006.
and gross profit. Our gross margin percentage was 63.5% in the three months ended March 31, 2006, compared with 63.4% in the same period last year due to sales growth in the higher margin

EXCERPTS ON THIS PAGE:

8-K
Oct 31, 2008
8-K
Aug 4, 2008
8-K
May 1, 2008
10-Q
May 10, 2006

RELATED TOPICS for EYE:

"and gross profit." elsewhere:

Boston Scientific (BSX)
Alphatec Holdings (ATEC)
Cantel Medical (CMN)
Conceptus (CPTS)
Haemonetics (HAE)
LeMaitre Vascular (LMAT)
Merit Medical Systems (MMSI)
NuVasive (NUVA)
Osteotech (OSTE)
STAAR Surgical Company (STAA)
Teleflex (TFX)
West Pharmaceutical Services (WST)
DENTSPLY International (XRAY)
Young Innovations (YDNT)
Zila (ZILA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki